Literature DB >> 1538462

Hypersensitivity systemic reaction following intravesical bacillus Calmette-Guerin: successful treatment with steroids.

J M Molina1, C Rabian, M F D'Agay, J Modai.   

Abstract

Intravesical bacillus Calmette-Guerin (BCG) is an effective treatment for superficial bladder carcinoma. Serious complications, including disseminated BCG infection, are infrequent. We report a case of granulomatous hepatitis with pneumonitis following intravesical administration of BCG. Cultures for mycobacteria were negative in sputum, bronchoalveolar lavage, liver and blood specimens. All symptoms disappeared within days after steroid therapy. Hypersensitivity reaction should be considered in patients with systemic symptoms after immunotherapy with BCG.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1538462     DOI: 10.1016/s0022-5347(17)37354-8

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  13 in total

1.  A case of BCG sepsis with bone marrow and liver involvement after intravesical BCG instillation.

Authors:  B Dederke; E O Riecken; T Weinke
Journal:  Infection       Date:  1998 Jan-Feb       Impact factor: 3.553

2.  Multi-organ failure with atypical liver granulomas following intravesical Bacillus Calmette-Guerin instillation.

Authors:  Michail Kaklamanos; Georgia Hardavella; Rodoula Trigidou; Georgios Dionellis; Nikolaos Paissios; Nikolaos Koulouris; Constantin Goritsas
Journal:  World J Hepatol       Date:  2011-03-27

3.  Granulomatous hepatitis following intravesical bacillus Calmette-Guerin therapy.

Authors:  B Ozbakkaloglu; O Tünger; S Sürücüoglu; M Lekili; A R Kandiloglu
Journal:  Int Urol Nephrol       Date:  1999       Impact factor: 2.370

4.  Granulomatous hepatitis caused by Bacillus Calmette-Guerin (BCG) infection after BCG bladder instillation.

Authors:  F W Leebeek; R J Ouwendijk; A H Kolk; A Dees; J C Meek; J E Nienhuis; A M Dingemans-Dumas
Journal:  Gut       Date:  1996-04       Impact factor: 23.059

5.  Subclinical miliary Mycobacterium bovis following BCG immunotherapy for transitional cell carcinoma of the bladder.

Authors:  Chang-Ho Ryan Choi; Sang Oh Lee; Geoff Smith
Journal:  BMJ Case Rep       Date:  2014-05-08

6.  Acute renal failure due to interstitial nephritis after intravesical instillation of BCG.

Authors:  Maria Jose Manzanera Escribano; Enrique Morales Ruiz; Mónica Odriozola Grijalba; Eduardo Gutierrez Martínez; Alfredo Rodriguez Antolín; Manuel Praga Terente
Journal:  Clin Exp Nephrol       Date:  2007-09-28       Impact factor: 2.801

7.  Hypersensitivity pneumonitis-like granulomatous lung disease with nontuberculous mycobacteria from exposure to hot water aerosols.

Authors:  Akshay Sood; Rajgopal Sreedhar; Pradeep Kulkarni; Abdur Ray Nawoor
Journal:  Environ Health Perspect       Date:  2006-11-06       Impact factor: 9.031

Review 8.  Bacillus Calmette-Guérin (BCG) infection following intravesical BCG administration as adjunctive therapy for bladder cancer: incidence, risk factors, and outcome in a single-institution series and review of the literature.

Authors:  María Asunción Pérez-Jacoiste Asín; Mario Fernández-Ruiz; Francisco López-Medrano; Carlos Lumbreras; Ángel Tejido; Rafael San Juan; Ana Arrebola-Pajares; Manuel Lizasoain; Santiago Prieto; José María Aguado
Journal:  Medicine (Baltimore)       Date:  2014-10       Impact factor: 1.889

9.  Peritoneal tuberculosis and granulomatous hepatitis secondary to treatment of bladder cancer with Bacillus Calmette-Guérin.

Authors:  Aliye Soylu; Ali T Ince; Hakan Polat; Nurgul Yasar; Aydin Ciltas; Selvinaz Ozkara; Ali I Tasci
Journal:  Ann Clin Microbiol Antimicrob       Date:  2009-04-15       Impact factor: 3.944

10.  Pleural Effusion Caused by Bacillus Calmette-Guérin Immunotherapy for Bladder Cancer.

Authors:  Tara Rachakonda; Brian Kendall; Adam M Spivak; Jonathan Boltax
Journal:  Open Forum Infect Dis       Date:  2017-06-17       Impact factor: 3.835

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.